Publicaciones en colaboración con investigadores/as de VU University Medical Center (19)

2023

  1. Author Correction: Discovery of 42 genome-wide significant loci associated with dyslexia (Nature Genetics, (2022), 54, 11, (1621-1629), 10.1038/s41588-022-01192-y)

    Nature Genetics

2022

  1. Discovery of 42 genome-wide significant loci associated with dyslexia

    Nature Genetics, Vol. 54, Núm. 11, pp. 1621-1629

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy

    American Journal of Human Genetics, Vol. 98, Núm. 6, pp. 1249-1255

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Antiproliferative effects of novel aliphatic acetogenin analogs against aggressive solid tumor cell lines

    In Vivo, Vol. 25, Núm. 2, pp. 203-207

  2. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

    Annals of the Rheumatic Diseases

2010

  1. Neuroanatomical tracing combined with in situ hybridization: Analysis of gene expression patterns within brain circuits of interest

    Journal of Neuroscience Methods, Vol. 194, Núm. 1, pp. 28-33

2008

  1. CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo

    Oncology Reports, Vol. 19, Núm. 6, pp. 1517-1523

  2. Origin of calretinin-containing, vesicular glutamate transporter 2-coexpressing fiber terminals in the entorhinal cortex of the rat

    Journal of Comparative Neurology, Vol. 506, Núm. 2, pp. 359-370

2007

  1. Mechanisms of action of FdUMP[10]: Metabolite activation and thymidylate synthase inhibition

    Oncology Reports, Vol. 18, Núm. 1, pp. 287-291

2006

  1. Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures

    Investigational New Drugs, Vol. 24, Núm. 3, pp. 195-202

2004

  1. Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2′-2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000

    Biochemical Pharmacology, Vol. 68, Núm. 4, pp. 601-609

2001

  1. Synthesis and in vitro cytotoxicity of novel long chain busulphan analogues

    Bioorganic and Medicinal Chemistry Letters, Vol. 11, Núm. 6, pp. 861-863

1999

  1. Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures

    Anti-Cancer Drugs, Vol. 10, Núm. 5, pp. 445-452

  2. Synthesis, in vitro cytotoxicity and in vivo anti-inflammatory activity of long chain 3-amino-1,2-diols

    Bioorganic and Medicinal Chemistry Letters, Vol. 9, Núm. 6, pp. 821-826